Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 4 » default
Journal of Hepatocellular Carcinoma
ISSN: 2253-5969
- View all (580)
- Volume 11, 2024 (56)
- Volume 10, 2023 (176)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Archive: Volume 4, 2017
Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator
Suryatenggara J, Wibowo H, Atmodjo WL, Mathew G
Journal of Hepatocellular Carcinoma 2017, 4:139-151
Published Date: 28 November 2017
Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions
Ray EM, Sanoff HK
Journal of Hepatocellular Carcinoma 2017, 4:131-138
Published Date: 8 November 2017
Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
Fateen W, Khan F, O’Neill RJ, James MW, Ryder SD, Aithal GP
Journal of Hepatocellular Carcinoma 2017, 4:123-130
Published Date: 16 October 2017
A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect
de la Torre AN, Contractor S, Castaneda I, Cathcart CS, Razdan D, Klyde D, Kisza P, Gonzales SF, Salazar AM
Journal of Hepatocellular Carcinoma 2017, 4:111-121
Published Date: 7 August 2017
Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
Sacco R, Tapete G, Simonetti N, Sellitri R, Natali V, Melissari S, Cabibbo G, Biscaglia L, Bresci G, Giacomelli L
Journal of Hepatocellular Carcinoma 2017, 4:105-110
Published Date: 27 July 2017
Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies
Galun D, Srdic-Rajic T, Bogdanovic A, Loncar Z, Zuvela M
Journal of Hepatocellular Carcinoma 2017, 4:93-103
Published Date: 11 July 2017
Hepatocellular carcinoma: early-stage management challenges
Erstad DJ, Tanabe KK
Journal of Hepatocellular Carcinoma 2017, 4:81-92
Published Date: 23 June 2017
Screening for hepatocellular carcinoma: patient selection and perspectives
Fateen W, Ryder SD
Journal of Hepatocellular Carcinoma 2017, 4:71-79
Published Date: 17 May 2017
Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L
Tarakanovskaya MG, Chinburen J, Batchuluun P, Munkhzaya C, Purevsuren G, Dandii D, Hulan T, Oyungerel D, Kutsyna GA, Reid AA, Borisova V, Bain AI, Jirathitikal V, Bourinbaiar AS
Journal of Hepatocellular Carcinoma 2017, 4:59-69
Published Date: 12 April 2017
Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives
Zimmerman A, Grand D, Charpentier KP
Journal of Hepatocellular Carcinoma 2017, 4:49-58
Published Date: 13 March 2017
A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus
Chotirosniramit A, Liwattanakun A, Lapisatepun W, Ko-iam W, Sandhu T, Junrungsee S
Journal of Hepatocellular Carcinoma 2017, 4:41-47
Published Date: 7 March 2017
Liver Imaging Reporting and Data System: an expert consensus statement
Elsayes KM, Kielar AZ, Agrons MM, Szklaruk J, Tang A, Bashir MR, Mitchell DG, Do RK, Fowler KJ, Chernyak V, Sirlin CB
Journal of Hepatocellular Carcinoma 2017, 4:29-39
Published Date: 17 February 2017
Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge
Francica G
Journal of Hepatocellular Carcinoma 2017, 4:23-27
Published Date: 20 January 2017
Pediatric hepatocellular carcinoma: challenges and solutions
Schmid I, von Schweinitz D
Journal of Hepatocellular Carcinoma 2017, 4:15-21
Published Date: 16 January 2017
Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients
Zhong J, Luo C, Zhang C, Li L
Journal of Hepatocellular Carcinoma 2017, 4:11-13
Published Date: 30 December 2016
Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration
Ma KW, Cheung TT
Journal of Hepatocellular Carcinoma 2017, 4:1-9
Published Date: 28 December 2016